Literature DB >> 8777058

Strategy for typing human papillomaviruses by RFLP analysis of PCR products and subsequent hybridization with a generic probe.

T Meyer1, R Arndt, E Stockfleth, H T Flammann, H Wolf, U Reischl.   

Abstract

Genital human papillomaviruses (HPV) were detected by PCR using L1 consensus primers MY09 and MY11. To determine the underlying HPV type(s). PCR products were subsequently analyzed employing a combination of restriction fragment length polymorphism (RFLP) and hybridization with a generic oligonucleotide probe that binds to a conserved region located close to the MY11-binding site within the PCR products. Using computer-assisted sequence analysis, the lengths of the corresponding BamHI, DdeI, HaeIII, HinfI and PstI restriction fragments hybridizing with the generic probe were calculated, revealing distinct patterns for each of the 45 mucosal HPV types. This method is superior to RFLP analysis since it is not impaired by large amounts of restriction fragments resulting from nonspecific PCR products. Moreover, considering clinical specimens containing two or three different HPV types, direct sequencing of PCR products will be inconclusive, and the increased number of restriction fragments will complicate interpretation of RFLP patterns. Subsequent hybridization with the generic probe, however, results in the appearance of, at most, 2 or 3 bands per restriction enzyme digest and thus facilitates identification of the underlying HPV types.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8777058

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  6 in total

1.  Detecting every genital papilloma virus infection: what does it mean?

Authors:  C P Crum
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

2.  In vitro infection and type-restricted antibody-mediated neutralization of authentic human papillomavirus type 16.

Authors:  W I White; S D Wilson; W Bonnez; R C Rose; S Koenig; J A Suzich
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

3.  Detection and quantitation of human papillomavirus by using the fluorescent 5' exonuclease assay.

Authors:  A Josefsson; K Livak; U Gyllensten
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

4.  Population-based type-specific prevalence of high-risk human papillomavirus infection in Estonia.

Authors:  Anneli Uusküla; Mart Kals; Liina Kosenkranius; Louise-Anne McNutt; Jack DeHovitz J
Journal:  BMC Infect Dis       Date:  2010-03-11       Impact factor: 3.090

5.  Detection and typing of human papillomaviruses combining different methods: polymerase chain reaction, restriction fragment length polymorphism, line probe assay and sequencing.

Authors:  Nina Milutin Gasperov; Ivan Sabol; Mihaela Matovina; Sime Spaventi; Magdalena Grce
Journal:  Pathol Oncol Res       Date:  2008-08-28       Impact factor: 3.201

6.  Transmission of human papillomavirus DNA from patient to surgical masks, gloves and oral mucosa of medical personnel during treatment of laryngeal papillomas and genital warts.

Authors:  Taru Ilmarinen; Eeva Auvinen; Eija Hiltunen-Back; Annamari Ranki; Leena-Maija Aaltonen; Anne Pitkäranta
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-05-16       Impact factor: 2.503

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.